Clinical Trials Arena July 24, 2025
As clinical trials become more complex, the ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger role for technology. We explore the latest Good Clinical Practice guidelines and what they mean for sponsors, CROs, and tech vendors.
The latest ICH E6 (R3) guidelines could transform how clinical studies are built and operated.
The updated ICH E6 (R3) guidelines introduce a range of critical changes aimed at modernizing clinical trials. These updates refine the way trials are designed and executed, with a focus on the increasingly vital role that technology plays in ensuring compliance, data integrity, and patient-centric outcomes.
The updates to guidelines were reorganized into a principles and objectives section, with Annex 1 (interventional trials) coming into...







